# The Human Medicines Regulations 2012, Regulation 74A: Obligation to provide information relating to methods of manufacture and control: MM medicinal products


The holder of a UK marketing authorisation relating to an MM medicinal product must provide the holder of the manufacturer’s licence (MM) relating to that product with information in order to enable the licence holder to ensure that the manufacturer’s licence (MM) and MM master file relating to the product are consistent with the marketing authorisation at all times.

---
Source: https://www.legislation.gov.uk/uksi/2012/1916/regulation/74A (the official version)
Page: https://openlegislation.uk/human-medicines-regulations-2012/regulation-74A
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.